Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Weimin Fan
Based on 15 articles published since 2009
(Why 15 articles?)
||||
Expertise Level
The expertise of Weimin Fan ranks in the
  • Top 1.6%
  • ... of 265,285 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 15 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    Zhejiang University      
2018
  • Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Breast Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Department of Breast Surgery, the First Affiliate Hospital of Zhejiang Chinese Medical University, Hangzhou 310014, China. · Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Clinical Research Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. · Pubmed 29125598
2017
  • Program of Cancer Innovative Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310000, China. · Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. · Clinical Research Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. · Department of Biological Sciences, National University of Singapore, 117543, Singapore. · Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. · Pubmed 28383557
  • Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China. · Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China. · Center for Cancer Biology and Innovative Therapeutics, Clinical Research Institute, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China. · Pubmed 28000875
2016
  • Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China. · Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China Clinical Research Center, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Biological Sciences, National University of Singapore, Singapore. · Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Chinese Academy of Science Key Laboratory for Infection and Immunity, IBP-UTSW Joint Immunotherapy Group, Institute of Biophysics, Chinese Academy of Sciences, Beijing, People's Republic of China. · Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA · Pubmed 27352928
  • Program of Innovative Cancer Therapeutics, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China. · Pubmed 26782109
2015
  • Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China. · Centre of Breast Cancer, Department of Surgery, First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China. · Pubmed 26306654
2014
  • Department of Biological Sciences, National University of Singapore, Singapore; Institute of Bioengineering and Nanotechnology, Singapore; Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Biological Sciences, National University of Singapore, Singapore; Institute of Bioengineering and Nanotechnology, Singapore; Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China · Pubmed 24972599
  • Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. · Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China. · Department of Biological Sciences, National University of Singapore, Singapore. · Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, USA. Electronic address: · Pubmed 24462822
2013
  • Program of Innovative Cancer Therapeutics, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China. · Pubmed 23531110
  • Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China. · Pubmed 22931419
  • Program of Innovative Cancer Therapeutics, Organ Transplantation Center of Zhejiang Province, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. · Pubmed 23499896
2012
  • Program of Innovative Cancer Therapeutics, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China. · Pubmed 22682751
  • Program of Innovative Cancer Therapeutics, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China. · Pubmed 22374518
Probable:    Medical University of South Carolina   Contact    
2018
  • Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Breast Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Department of Breast Surgery, the First Affiliate Hospital of Zhejiang Chinese Medical University, Hangzhou 310014, China. · Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Clinical Research Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. · Pubmed 29125598
2017
  • Program of Cancer Innovative Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310000, China. · Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. · Clinical Research Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. · Department of Biological Sciences, National University of Singapore, 117543, Singapore. · Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. · Pubmed 28383557
2016
  • Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China. · Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China Clinical Research Center, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Biological Sciences, National University of Singapore, Singapore. · Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Chinese Academy of Science Key Laboratory for Infection and Immunity, IBP-UTSW Joint Immunotherapy Group, Institute of Biophysics, Chinese Academy of Sciences, Beijing, People's Republic of China. · Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA · Pubmed 27352928
2015
  • a Program of Innovative Cancer Therapeutics; Department of Surgery. · b Clinical Research Center; First Affiliated Hospital of Zhejiang University School of Medicine ; Hangzhou , China. · c Department of Biological Sciences ; National University of Singapore ; Singapore. · d Department of Pathology and Laboratory Medicine ; Medical University of South Carolina ; SC , USA. · Pubmed 26529585
2014
  • Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. · Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China. · Department of Biological Sciences, National University of Singapore, Singapore. · Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, USA. Electronic address: · Pubmed 24462822
Probable:    National University Singapore      
2014
  • Department of Biological Sciences, National University of Singapore, Singapore; Institute of Bioengineering and Nanotechnology, Singapore; Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Biological Sciences, National University of Singapore, Singapore; Institute of Bioengineering and Nanotechnology, Singapore; Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China · Pubmed 24972599
2013
  • Department of Biological Sciences, National University of Singapore, Singapore, Singapore. · Pubmed 23752308
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 15 total) written by Weimin Fan about Breast Neoplasms:

  • A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance. 2018
  • Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer. 2017
  • Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression. 2017
  • Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth. 2016
  • Distinct characterization of two vinorelbine-resistant breast cancer cell lines developed by different strategies. 2016
  • Endocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies. 2015
  • Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells. 2015
  • Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model. 2014
  • Fulvestrant, a selective estrogen receptor down-regulator, sensitizes estrogen receptor negative breast tumors to chemotherapy. 2014
  • Novel targeted therapies to overcome trastuzumab resistance in HER2-overexpressing metastatic breast cancer. 2013
Show List of Full Article Records
Google Searches

Learn more about Weimin Fan using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Zhejiang University
Medical University of South Carolina
National University Singapore
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Zhejiang University
2018
  • Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Breast Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Department of Breast Surgery, the First Affiliate Hospital of Zhejiang Chinese Medical University, Hangzhou 310014, China. · Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Clinical Research Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. · Pubmed 29125598
2017
  • Program of Cancer Innovative Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310000, China. · Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. · Clinical Research Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. · Department of Biological Sciences, National University of Singapore, 117543, Singapore. · Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. · Pubmed 28383557
  • Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China. · Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China. · Center for Cancer Biology and Innovative Therapeutics, Clinical Research Institute, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China. · Pubmed 28000875
2016
  • Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China. · Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China Clinical Research Center, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Biological Sciences, National University of Singapore, Singapore. · Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Chinese Academy of Science Key Laboratory for Infection and Immunity, IBP-UTSW Joint Immunotherapy Group, Institute of Biophysics, Chinese Academy of Sciences, Beijing, People's Republic of China. · Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA · Pubmed 27352928
  • Program of Innovative Cancer Therapeutics, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China. · Pubmed 26782109
2015
  • Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China. · Centre of Breast Cancer, Department of Surgery, First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China. · Pubmed 26306654
2014
  • Department of Biological Sciences, National University of Singapore, Singapore; Institute of Bioengineering and Nanotechnology, Singapore; Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Biological Sciences, National University of Singapore, Singapore; Institute of Bioengineering and Nanotechnology, Singapore; Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China · Pubmed 24972599
  • Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. · Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China. · Department of Biological Sciences, National University of Singapore, Singapore. · Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, USA. Electronic address: · Pubmed 24462822
2013
  • Program of Innovative Cancer Therapeutics, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China. · Pubmed 23531110
  • Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China. · Pubmed 22931419
  • Program of Innovative Cancer Therapeutics, Organ Transplantation Center of Zhejiang Province, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. · Pubmed 23499896
2012
  • Program of Innovative Cancer Therapeutics, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China. · Pubmed 22682751
  • Program of Innovative Cancer Therapeutics, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China. · Pubmed 22374518
Medical University of South Carolina
2018
  • Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Breast Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Department of Breast Surgery, the First Affiliate Hospital of Zhejiang Chinese Medical University, Hangzhou 310014, China. · Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Clinical Research Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310003, China. · Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. · Pubmed 29125598
2017
  • Program of Cancer Innovative Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310000, China. · Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. · Clinical Research Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. · Department of Biological Sciences, National University of Singapore, 117543, Singapore. · Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. · Pubmed 28383557
2016
  • Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China. · Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China Clinical Research Center, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Biological Sciences, National University of Singapore, Singapore. · Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Chinese Academy of Science Key Laboratory for Infection and Immunity, IBP-UTSW Joint Immunotherapy Group, Institute of Biophysics, Chinese Academy of Sciences, Beijing, People's Republic of China. · Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA · Pubmed 27352928
2015
  • a Program of Innovative Cancer Therapeutics; Department of Surgery. · b Clinical Research Center; First Affiliated Hospital of Zhejiang University School of Medicine ; Hangzhou , China. · c Department of Biological Sciences ; National University of Singapore ; Singapore. · d Department of Pathology and Laboratory Medicine ; Medical University of South Carolina ; SC , USA. · Pubmed 26529585
2014
  • Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. · Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China. · Department of Biological Sciences, National University of Singapore, Singapore. · Program of Innovative Cancer Therapeutics, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, USA. Electronic address: · Pubmed 24462822
Unspecified
2015
  • a Program of Innovative Cancer Therapeutics; Department of Surgery. · b Clinical Research Center; First Affiliated Hospital of Zhejiang University School of Medicine ; Hangzhou , China. · c Department of Biological Sciences ; National University of Singapore ; Singapore. · d Department of Pathology and Laboratory Medicine ; Medical University of South Carolina ; SC , USA. · Pubmed 26529585
National University Singapore
2014
  • Department of Biological Sciences, National University of Singapore, Singapore; Institute of Bioengineering and Nanotechnology, Singapore; Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China. · Department of Biological Sciences, National University of Singapore, Singapore; Institute of Bioengineering and Nanotechnology, Singapore; Program of Innovative Cancer Therapeutics, Department of Surgery, First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People's Republic of China · Pubmed 24972599
2013
  • Department of Biological Sciences, National University of Singapore, Singapore, Singapore. · Pubmed 23752308
Yearly article counts 01222242000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.